Sibutramine is a serotonin and noradrenaline reuptake inhibitor exerting a
weight reducing effect partly via its anorectic properties. We investigated
the effects of 15 mg sibutramine on objective (intake) and subjective (sen
sations) parameters of eating behavior in 24 young male subjects. At 0830 h
subjects took either placebo or sibutramine in a counterbalanced order, fo
llowed by a fixed amount of breakfast. Intake was covertly recorded in the
laboratory until the dinner meal, and then until the next morning using dia
ry reports. Sibutramine induced a highly significant reduction in energy (1
304 kJ, p < 0.001), protein (294 kJ, p < 0.001), fat (414 kJ, p < 0.01), an
d carbohydrate (CHO, 594 kJ, p < 0.001) intakes compared to placebo. This r
eduction was further enhanced when 24-h intake was analyzed (1601 kJ,p < 0.
001). The effect of sibutramine occurred mainly at lunch (637 kJ, p = 0.005
). Throughout the test day the number of items consumed and the weight of f
ood were reduced by sibutramine (1.6, p < 0.01 and 222 g, p < 0.001, respec
tively), whereas energy density was not changed. Meals minus dessert items
were the most altered by sibutramine. A specific CHO reduction was found in
the dinner meal, although the proportions of macronutrients in total daily
energy intake were not changed by sibutramine. Hunger ratings began to be
lower than placebo 240 min after sibutramine. These results show that a sin
gle dose of sibutramine in lean humans induces a po tent reduction in intak
e, and that its action is modulated according to the time of occurrence and
the structure of the meal. (C) 2000 Elsevier Science Inc. All rights reser
ved.